Eagle LogoPEPTIDE INITIATIVE

Peptide Database

Goals
Fat LossMuscle BuildingInjury HealingAnti-AgingCognitive EnhancementSleep OptimizationImmune SupportGut HealingSkin RejuvenationSexual Health
Peptides
5-Amino-1MQ
Weight Management
Abarelix
Hormone Support
Acetyl Hexapeptide-3 (Argireline)
Cosmetic
Adipotide
Weight Management
Adrenomedullin
Healing & Recovery
Alexamorelin
Growth Hormone
Angiotensin (1-7)
Healing & Recovery
AOD-9604
Weight Management
Apelin-13
Healing & Recovery
ARA-290 (Cibinetide)
Healing & Recovery
Bestatin (Ubenimex)
Immune
BPC-157
Healing & Recovery
Buserelin
Hormone Support
Cagrilintide
Weight Management
CagriSema
Weight Management
Capromorelin
Growth Hormone
Cartalax
Anti-Aging
Cathelicidin (hCAP-18 / Synthetic Derivatives)
Immune
Cerebrolysin
Cognitive
Cerluten
Cognitive
Cetrorelix
Hormone Support
Chonluten
Immune
CJC-1295 (No DAC)
Growth Hormone
CJC-1295 with DAC
Growth Hormone
Copper Tripeptide-1 (GHK-Cu)
Cosmetic
Cortexin
Cognitive
Crystagen
Immune
Daptomycin
Immune
Defensin (HBD-2)
Immune
Defensin (HBD-3)
Immune
Degarelix
Hormone Support
Dihexa
Cognitive
DSIP (Delta Sleep-Inducing Peptide)
Sleep & Recovery
Dulaglutide
Weight Management
Enalapril
Healing & Recovery
Epithalon
Anti-Aging
Exenatide
Weight Management
Fertirelin
Hormone Support
FOXO4-DRI
Anti-Aging
Ganirelix
Hormone Support
GHK-Cu (Copper Peptide)
Cosmetic
GHRH (1-29)
Growth Hormone
GHRP-2
Growth Hormone
GHRP-6 (Growth Hormone Releasing Peptide-6)
Growth Hormone
Glutathione
Anti-Aging
Gonadorelin (GnRH)
Hormone Support
Gramicidin
Immune
Hexarelin
Growth Hormone
Human Chorionic Gonadotropin (HCG)
Hormone Support
Human Growth Hormone (HGH)
Growth Hormone
IGF-1 LR3
Growth Hormone
Immunoxel (Dzherelo)
Immune
Imunofan
Immune
Intermedin (Adrenomedullin-2)
Healing & Recovery
Ipamorelin
Growth Hormone
Kisspeptin-10
Sexual Health
KPV (Alpha-MSH Fragment)
Healing & Recovery
Lactoferricin B
Immune
Larazotide
Healing & Recovery
Lentinan
Immune
Leuphasyl
Cosmetic
Leuphasyl
Cosmetic
Leuprolide
Hormone Support
Liraglutide
Weight Management
Livagen
Anti-Aging
Lixisenatide
Weight Management
LL-37
Immune
Macimorelin
Growth Hormone
Magainin-2
Immune
Mazdutide
Weight Management
Melanotan-2
Cosmetic
MK-677 (Ibutamoren)
Growth Hormone
MOTS-c
Metabolic
Myristoyl Pentapeptide-17
Cosmetic
N-Acetyl Selank
Cognitive
N-Acetyl Semax Amidate
Cognitive
NAD+
Mitochondrial
Nafarelin
Hormone Support
Natriuretic Peptide (ANP)
Healing & Recovery
Nesiritide (BNP)
Healing & Recovery
Nisin
Immune
Noopept (Omberacetam)
Cognitive
Orforglipron
Weight Management
Ovagen
Anti-Aging
Oxytocin Acetate
Hormone Support
P21 (P021)
Cognitive
PACAP-38
Healing & Recovery
Palmitoyl Oligopeptide
Cosmetic
Palmitoyl Pentapeptide-4 (Matrixyl)
Cosmetic
Palmitoyl Tetrapeptide-7
Cosmetic
Palmitoyl Tripeptide-1
Cosmetic
Pancragen
Metabolic
PEG-MGF
Healing & Recovery
Pemvidutide
Weight Management
Pentadecapeptide (BPC Analog)
Healing & Recovery
Pidotimod
Immune
Pinealon
Cognitive
PNC-27
Immune
Polymyxin B
Immune
Pralmorelin (GHRP-2)
Growth Hormone
Pramlintide
Weight Management
Prostamax
Hormone Support
PT-141 (Bremelanotide)
Sexual Health
Relaxin-2 (Serelaxin)
Healing & Recovery
Retatrutide
Weight Management
Selank
Cognitive
Semaglutide
Weight Management
Semax
Cognitive
Sermorelin
Growth Hormone
Setmelanotide
Weight Management
SLU-PP-332
Metabolic
SM-130686
Growth Hormone
Snap-8
Cosmetic
SS-31 (Elamipretide)
Mitochondrial
Substance P Antagonists
Healing & Recovery
Survodutide
Weight Management
SYN-AKE
Cosmetic
Tabimorelin
Growth Hormone
TB-500
Healing & Recovery
Tesamorelin
Growth Hormone
Testagen
Hormone Support
Thymalin
Immune
Thymopentin (TP-5)
Immune
Thymopoietin
Immune
Thymosin Alpha-1
Immune
Thymosin Beta-4
Healing & Recovery
Thymulin (FTS)
Immune
Thymulin Analog (PAT)
Healing & Recovery
Tirzepatide
Weight Management
Tripeptide-29
Cosmetic
Triptorelin
Hormone Support
Ularitide
Healing & Recovery
Urocortin
Healing & Recovery
Ventfort
Anti-Aging
Vesilute
Hormone Support
Vilon
Immune
VIP (Vasoactive Intestinal Peptide)
Healing & Recovery
Xenin-25
Metabolic
Ziconotide (Prialt)
Healing & Recovery
Total Peptides: 139
Back to Home

IGF-1 LR3

A supercharged version of your body's own growth factor that stays active 2-3 times longer than regular IGF-1, making it a powerhouse for muscle growth, recovery, and cellular regeneration.

Written by Michael CarrollOwner, Director of Research · Reviewed by the Peptide Initiative Research Team

Growth HormoneResearch compound

Typical dose

20–100 mcg

Once dailyCycle: 4-6 weeksOnset: Rapid (hours to days)
20-30 hoursHalf-life
High when injected subcutaneously or intramuscularlyBioavailability
9111.4 g/molMolecular weight
Strong preclinicalEvidence level

Compound profile

Scientific & efficacy data

Growth Hormone

Peptide profile

Muscle Growth9.6
Recovery Speed9.2
Nutrient Utilization8.8

Strong preclinical

IGF-1 LR3

20–100 mcg · Once daily

Molecular formula

C400H625N111O115S9

Mol. weight
9111.4 g/mol
CAS number
946870-92-4
PubChem
Not assigned
Developed · 1987
Francis John Ballard and colleagues
CSIRO Division of Human Nutrition, Adelaide, Australia

Amino acid sequence

MFPAMPLSSL FVNGPRTLCG AELVDALQFV CGDRGFYFNK PTGYGSSSRR APQTGIVDEC CFRSCDLRRL EMYCAPLKPA KSA (83 amino acids with Arg3 substitution and 13 amino acid N-terminal extension)

Muscle Growth

One of the most potent peptides for muscle building through both hypertrophy and hyperplasia mechanisms

Recovery Speed

Significantly accelerates post-workout recovery and tissue repair, allowing more frequent intense training

Nutrient Utilization

Enhances how efficiently your body uses protein and carbohydrates for muscle building versus fat storage

Dosing

How much do I take?

Full IGF-1 LR3 dosing protocol

Covers timing · dose-adjustment guidance.

IGF-1 LR3Three quick questions

How much peptide is in your bottle?

Look at the label on the vial. It’s the number next to mg — like "5 mg".

Type a number to continue.
0

Suitability

Is this right for me?

Best for muscle growth and hypertrophy & post-workout recovery

Best for

Serious Muscle Builders

If you're pushing hard in the gym and want to maximize every rep, IGF-1 LR3 helps your muscles grow through both hypertrophy (bigger cells) AND hyperplasia (more cells) [2]. That's a one-two punch that few other compounds offer.

Recovery-Focused Athletes

Train hard, recover faster. IGF-1 LR3 accelerates tissue repair and reduces the time you need between intense sessions [14]. It's particularly valuable during high-volume training blocks or when preparing for competition.

Body Recomposition Goals

Looking to build muscle while losing fat? IGF-1 LR3 helps shuttle nutrients into muscle cells while improving how your body uses fat for fuel [8][15]. Combined with proper diet, it supports that lean, muscular physique.

Post-Injury Rehabilitation

IGF-1 is your body's natural repair signal. The LR3 version stays active longer, potentially helping injured tissues heal more completely [1][5]. Athletes recovering from muscle strains or tears may find it particularly beneficial.

Consider alternatives if

Muscle growth with less hypoglycemia riskMGF (Mechano Growth Factor), CJC-1295 + Ipamorelin, GHRP-2
General anti-aging and recoveryBPC-157, TB-500, GHK-Cu
Fat loss with muscle preservationTesamorelin, HGH Fragment 176-191, Ipamorelin

Do not use if

You have active cancer or a history of cancer—IGF-1 can stimulate cell growth including potentially cancerous cellsYou are pregnant or breastfeeding—effects on fetal/infant development are unknownYou have diabetic retinopathy—IGF-1 may accelerate eye blood vessel growthYou have uncontrolled diabetes—blood sugar management becomes extremely difficultYou are under 21—can affect natural growth plate closure and hormonal developmentYou've had allergic reactions to IGF-1 or similar peptides

Use with caution if

You have any insulin resistance or pre-diabetes—monitor blood sugar very carefullyYou take medications that affect blood sugar levels—interactions can be dangerousYou have heart conditions—IGF-1 can cause cardiac tissue growthYou have kidney or liver issues—may affect peptide metabolismYou have carpal tunnel syndrome—IGF-1 can worsen symptomsYou have a family history of cancer—discuss with your doctor first

Not sure?

Compare IGF-1 LR3 with similar peptides to find the best fit for your goals.

Administration

How do I use it?

Subcutaneous injection · Intramuscular injection

Route

Subcutaneous injection (under the skin) is most common; intramuscular injection into specific muscles is also used for localized effects

Best sites

Abdomen (2 inches from belly button)—most common for subcutaneousTarget muscle (bicep, quad, etc.)—for site-specific enhancementFront or outer thigh—alternative subcutaneous siteUpper arm fat pad—another subcutaneous option

Covers reconstitution · step-by-step technique · storage · a sample daily schedule.

Safety

Is it safe?

4 common side effects · 2 serious

IGF-1 LR3 has been extensively studied in research settings and shows a predictable side effect profile when used responsibly.

The primary concern is hypoglycemia, which is manageable with proper nutrition timing [7][9]. Long-term safety data in humans is limited since it's used as a research compound. Joint discomfort and water retention are generally mild and resolve when cycling off.

Most safety data comes from animal studies and limited human research contexts. While these suggest a favorable profile at moderate doses, large-scale human clinical trials haven't been conducted. Always work with a healthcare provider familiar with peptide research when using any research compound.

Common side effects · experienced by some users

  • Hypoglycemia (low blood sugar)

    This is the most important side effect to understand. IGF-1 LR3 acts like insulin and drives glucose into cells, which can leave you feeling shaky, dizzy, or weak [7][8].

    Management: Always eat within 30 minutes of injection. Keep fast-acting carbs (juice, glucose tablets) nearby. Learn your body's warning signs: shakiness, sweating, hunger, confusion.

  • Injection site reactions

    Redness, slight swelling, or itching at the injection site is normal and usually fades within a day.

    Management: Rotate injection sites regularly. Use proper sterile technique. A cool compress can help if irritation occurs.

  • Water retention

    Some puffiness or bloating, especially in hands and face, as IGF-1 causes cells to hold more water [16].

    Management: Usually mild and temporary. Moderate sodium intake, stay well-hydrated, and it typically resolves as your body adjusts or when you cycle off.

  • Headaches

    Particularly common in the first week as your body adjusts to the peptide.

    Management: Stay hydrated, don't skip meals, and the headaches usually subside after the first week. If persistent, consider reducing dose.

Less common

Joint pain or stiffnessNumbness or tingling

These typically resolve with continued use or dose adjustment.

Stop and seek help if

  • Any severe hypoglycemic episode that doesn't resolve quickly with food
  • Persistent numbness, tingling, or carpal tunnel symptoms
  • Joint pain that interferes with training or daily activities
  • Signs of allergic reaction (rash, swelling, difficulty breathing)
  • Any concerning or unusual symptoms that worry you
  • Completion of your planned cycle (typically 4-6 weeks)

IGF-1 LR3 is a research compound, not approved for human therapeutic use by the FDA. This information is for educational purposes only and not medical advice. Always consult with a healthcare provider before starting, stopping, or modifying any research protocol.

With other peptides

  • Safe:MGF (Mechano Growth Factor)Potentially synergistic for muscle growth. MGF works locally while IGF-1 LR3 works systemically. Can be used together with careful timing.
  • Safe:CJC-1295Can be stacked for complementary effects—CJC increases natural GH release while IGF-1 LR3 provides direct IGF effects. Space injections apart.
  • Safe:GHRP-6Safe to combine. GHRP-6 stimulates hunger which can actually help prevent hypoglycemia from IGF-1 LR3.
  • Caution:InsulinDANGEROUS combination. Both lower blood sugar dramatically. Severe hypoglycemia risk. Do NOT combine unless under strict medical supervision.

With medications

  • Caution:Diabetes medications (Metformin, Sulfonylureas)Increased hypoglycemia risk. Blood sugar-lowering effects compound dangerously. Requires medical supervision and dose adjustments.
  • Caution:Insulin (medical)Extremely dangerous combination. Both dramatically lower blood sugar. Can cause severe, life-threatening hypoglycemia.
  • Safe:Blood thinners (Warfarin, etc.)May increase bruising at injection sites. Not dangerous but worth monitoring.
  • Caution:Beta-blockersCan mask hypoglycemia symptoms (shakiness, rapid heartbeat), making low blood sugar harder to detect. Use with caution.

With supplements

  • Safe:CreatineSafe and potentially complementary. Both support muscle cell function and recovery.
  • Safe:Protein supplementsHighly recommended! Adequate protein maximizes IGF-1 LR3 benefits. Take protein with or shortly after injection.
  • Safe:ChromiumMay enhance insulin sensitivity, potentially increasing hypoglycemia risk. Monitor blood sugar more carefully.
  • Safe:Alpha-Lipoic Acid (ALA)Can increase glucose uptake, compounding hypoglycemia risk. Use lower doses of both if combining.

Effectiveness

How do I know it's working?

Strong preclinical · first signs week 1

Evidence level

Strong preclinical

(extensive animal studies)

70/100

Regulatory status

Research compound

Onset of effects

Rapid

(hours to days)

How it works

Think of IGF-1 as your body's building signal—it tells cells to grow, repair, and multiply.

Regular IGF-1 gets grabbed by binding proteins almost immediately, like trying to deliver a package but everyone keeps intercepting it [3]. IGF-1 LR3 is modified so those binding proteins can't hold onto it [1]. The result?

It circulates freely instead of being bound and inactivated within minutes, actually reaching your muscles and telling them to grow.

Plus, unlike most growth factors that only make cells bigger, IGF-1 can trigger the creation of entirely new muscle cells—that's hyperplasia, and it's the holy grail of muscle building [2].

The deeper mechanism

IGF-1 LR3 (Long Arginine 3-IGF-1) is a modified 83-amino acid analog of human IGF-1. The key modifications include a 13-amino acid extension at the N-terminus and substitution of Arg for Glu at position 3.

These changes reduce binding affinity for IGF binding proteins (IGFBPs) by approximately 1000-fold, dramatically increasing the fraction that circulates free and biologically active [6].

IGF-1 LR3 binds the Type 1 IGF receptor (IGF-1R) with somewhat lower (about 3-fold) affinity than native IGF-1 [17], activating downstream PI3K/Akt and Ras/MAPK/ERK signaling cascades [2].

The PI3K/Akt pathway promotes protein synthesis via mTOR activation and inhibits protein degradation through FOXO transcription factor suppression [11][12]. The ERK pathway mediates proliferative effects [2].

Unlike most anabolic agents that primarily induce hypertrophy (cell enlargement), IGF-1 uniquely promotes satellite cell activation and hyperplasia (new muscle fiber formation) [2][13].

Its insulin-like activity at supraphysiological concentrations accounts for hypoglycemia risk through glucose transporter (GLUT4) translocation and enhanced cellular glucose uptake [7][8].

What to expect

  1. Week 1

    What you might notice

    • Increased muscle fullness and pumps during workouts
    • Possible hypoglycemia symptoms as you learn dosing/eating timing
    • Mild headaches as your body adjusts
    • Perhaps some water retention (slight puffiness)
    • Improved workout recovery already beginning

    What's normal

    • Needing to eat more frequently to prevent low blood sugar
    • Some initial side effects that should diminish
    • Your muscles looking and feeling fuller

    What's next

    • Continue dialing in your nutrition timing
    • Keep carbs accessible for hypoglycemia prevention
    • Maintain consistent injection schedule
  2. Week 2-3

    What you might notice

    • Noticeable improvements in workout recovery speed
    • Muscle gains becoming more apparent
    • Side effects typically stabilizing or diminishing
    • Better nutrient partitioning—muscles look fuller, potentially leaner
    • Improved strength and training capacity

    What's normal

    • Settling into a routine with injection and eating timing
    • Continued muscle fullness and improved pumps
    • Energy levels stabilizing

    What's next

    • Maintain consistent protocol
    • Consider slight dose adjustment if needed
    • Continue tracking progress and any side effects
  3. Week 4-6

    What you might notice

    • Peak effects—maximum muscle growth and recovery benefits
    • Measurable gains in muscle size and strength
    • Body composition improvements (more muscle, potentially less fat)
    • Excellent workout recovery
    • Possible receptor downregulation if extended beyond 6 weeks

    What's normal

    • Best results typically seen during this period
    • Stable side effect profile
    • Feeling strong and recovered

    What's next

    • Complete cycle at 4-6 weeks
    • Begin planning off-cycle period (4+ weeks)
    • Maintain training intensity to preserve gains
  4. Post-cycle (off period)

    What you might notice

    • Gradual return to baseline muscle fullness
    • Maintained muscle gains if training and nutrition stay consistent
    • No withdrawal effects—you simply stop
    • Side effects resolve completely within days

    What's normal

    • Slight reduction in muscle pump and fullness
    • Return of normal blood sugar patterns
    • Maintained strength and most muscle gains

    What's next

    • Continue solid training and nutrition
    • Take at least 4 weeks off to reset receptors
    • Plan next cycle if desired

Signs it's working

Muscle Growth Indicators

  • Increased muscle fullness and pump during training
  • Visible improvements in muscle size within 2-3 weeks
  • Clothes fitting tighter in the chest, arms, and shoulders
  • Improved vascularity when lean
  • Strength gains in major lifts

Recovery Indicators

  • Less muscle soreness after intense training
  • Ability to train more frequently without overtraining
  • Faster return to peak performance between sessions
  • Reduced fatigue during high-volume training blocks

Body Composition Indicators

  • Improved muscle-to-fat ratio
  • More defined muscle separation
  • Better nutrient partitioning (muscles seem to absorb food better)
  • Maintained or reduced body fat despite calorie surplus

Not seeing results? Common reasons

  • Blood sugar management issues—if you're constantly hypoglycemic, you may not be eating enough around injections, limiting results
  • Peptide degradation—improper storage is a common culprit; always check solution clarity and storage conditions
  • Dose too low—starting doses are conservative; you may need to increase after assessing tolerance
  • Poor quality product—only purchase from verified sources with third-party testing certificates (COAs)
  • Insufficient training stimulus—IGF-1 LR3 enhances your body's response to training, but you still need to train hard
  • Inadequate nutrition—not enough protein or calories limits the peptide's ability to build muscle

Key research

2001[1]
Long R3 IGF-I differently affect development and messenger ribonucleic acid abundance for IGF-binding proteins and type I IGF receptors in bovine embryosPrelle K, Stojkovic M, et al.Finding: This foundational study demonstrated that LR3 IGF-I has dramatically reduced binding to IGF binding proteins compared to regular IGF-1, explaining why it remains active in the bloodstream much longer and has greater bioavailability for tissue effects.View study
2003[2]
Extracellular signal-regulated kinase and phosphoinositol-3 kinase mediate IGF-1 induced proliferation of fetal cardiomyocytesSundgren NC, Giraud GD, et al.Finding: Researchers found that Long R3 IGF-I stimulates cell proliferation (hyperplasia) through both ERK and PI3K signaling pathways—this explains the unique ability of IGF-1 to create new cells, not just make existing cells bigger.View study
2003[3]
IGF-I and IGFBP-3 transport in the rat heartBoes M, Dake BL, et al.Finding: This study showed that LR3 IGF-I can bypass IGF binding proteins that normally sequester IGF-1, demonstrating why LR3 has greater bioactivity—it reaches target tissues more effectively than native IGF-1.View study
2019[4]
Inhibition of activin-like kinase 4/5 attenuates cancer cachexia associated muscle wastingLevolger S, Wiemer EAC, et al.Finding: LR3 IGF-I treatment effectively limited muscle mass loss in a cancer cachexia model, demonstrating its potent anti-catabolic effects and ability to preserve muscle tissue under conditions that normally cause severe muscle wasting.View study
2023[5]
Recombinant expression of IGF-1 and LR3 IGF-1 fused with xylanase in Pichia pastorisLu Z, Liu N, et al.Finding: Purified LR3 IGF-1 displayed excellent bioactivity for cell proliferation comparable to standard IGF-1, confirming that the molecular modifications preserve its biological function while extending its active lifespan.View study
1993[6]
Effects of interactions between IGFBPs and IGFs on the plasma clearance and in vivo biological activities of IGFs and IGF analogsBallard FJ, Walton PE, Bastian S, Tomas FM, Wallace JC, Francis GLFinding: In direct comparisons, IGF-I bound IGF-binding proteins (IGFBP-3, IGFBP-4 and total rat plasma IGFBPs) with approximately 1000-fold higher affinity than LR3 IGF-I, and the weaker binding gave LR3 IGF-I 5-10 times greater potency in cultured myoblasts and 6 times greater growth potency in rats. The same study found that LR3 IGF-I was cleared from rat plasma more rapidly than IGF-I, precisely because it does not associate with binding proteins.View study
1997[7]
IGF-I variants which bind poorly to IGF-binding proteins show more potent and prolonged hypoglycaemic action than native IGF-I in pigs and marmoset monkeysTomas FM, Walton PE, Dunshea FR, Ballard FJFinding: In pigs and marmoset monkeys, IGF-I variants that bind poorly to IGF-binding proteins, including LR3 IGF-I, lowered blood glucose 2- to 3-fold more potently than native IGF-I and kept glucose suppressed over a much longer period, giving a roughly 4- to 8-fold larger cumulative hypoglycaemic effect.View study
1992[8]
Acute and long-term effects of insulin-like growth factor I on glucose transporters in muscle cells. Translocation and biosynthesisBilan PJ, Mitsumoto Y, Ramlal T, Klip AFinding: In muscle cells, IGF-I raised glucose uptake within about 10 minutes by moving glucose transporters (GLUT1 and GLUT4) to the cell surface, with no new protein synthesis required. Longer exposure additionally increased the amount of transporter the cells made.View study
2025[9]
INCRELEX (mecasermin injection) FDA prescribing informationIpsen Biopharmaceuticals, Inc.Finding: The FDA label for mecasermin (recombinant human IGF-1) reports hypoglycemia in 30 of 71 trial subjects (42%), including 5 severe episodes and 4 hypoglycemic seizures, and directs that each dose be given shortly before or after (plus or minus 20 minutes) a meal or snack, and not given if the meal is skipped.View study
2001[10]
The somatomedin hypothesis: 2001Le Roith D, Bondy C, Yakar S, Liu JL, Butler AFinding: This review describes the growth hormone/IGF-1 axis, in which pituitary GH stimulates the liver to produce IGF-1 that supplies most of the IGF-1 in the bloodstream. It also reviews evidence that IGF-1 made locally in other tissues contributes to growth, since mice lacking liver IGF-1 still grow normally despite a large drop in circulating IGF-1.View study
2001[11]
Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K/Akt/mTOR and PI(3)K/Akt/GSK3 pathwaysRommel C, Bodine SC, Clarke BA, Rossman R, Nunez L, Stitt TN, Yancopoulos GD, Glass DJFinding: IGF-1 enlarged cultured muscle fibers through PI3K/Akt signaling, with Akt driving growth by activating the mTOR pathway and by inhibiting GSK3, both routes previously linked to increased protein synthesis.View study
2004[12]
The IGF-1/PI3K/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factorsStitt TN, Drujan D, Clarke BA, Panaro F, Timofeyva Y, Kline WO, Gonzalez M, Yancopoulos GD, Glass DJFinding: IGF-1 signaling through PI3K/Akt blocked production of the muscle-wasting ubiquitin ligases MAFbx/atrogin-1 and MuRF1 by inhibiting FOXO transcription factors, which is the route by which IGF-1 suppresses muscle protein breakdown.View study
2000[13]
Insulin-like growth factor-I extends in vitro replicative life span of skeletal muscle satellite cells by enhancing G1/S cell cycle progression via the activation of phosphatidylinositol 3'-kinase/Akt signaling pathwayChakravarthy MV, Abraha TW, Schwartz RJ, Fiorotto ML, Booth FWFinding: IGF-I kept skeletal muscle satellite cells dividing for at least five population doublings beyond the normal limit, acting through PI3K/Akt signaling and reduced p27(Kip1) to speed passage through the G1/S checkpoint.View study
2007[14]
Local expression of IGF-1 accelerates muscle regeneration by rapidly modulating inflammatory cytokines and chemokinesPelosi L, Giacinti C, Nardis C, Borsellino G, Rizzuto E, Nicoletti C, Wannenes F, Battistini L, Rosenthal N, Molinaro M, Musaro AFinding: Mice engineered to express IGF-1 in muscle repaired injured muscle faster than normal mice, with a quicker drop in pro-inflammatory cytokines and less fibrous scarring. The effect was measured after experimental injury in mice, not after training in humans.View study
1995[15]
The effects of recombinant human insulin-like growth factor-I and growth hormone on body composition in elderly womenThompson JL, Butterfield GE, Marcus R, Hintz RL, Van Loan M, Ghiron L, Hoffman ARFinding: Sixteen healthy elderly women received recombinant human IGF-1 or GH for four weeks. Fat mass fell in all groups, and lean body mass and nitrogen retention rose significantly in the high-dose IGF-1 and GH groups. The high dose also produced side effects including headaches and joint swelling, while the low IGF-1 dose was well tolerated.View study
2005[16]
rhIGF-I/rhIGFBP-3 administration to patients with type 2 diabetes mellitus reduces insulin requirements while also lowering fasting glucoseClemmons DR, Moses AC, Sommer A, Jacobson W, Rogol AD, Sleevi MR, Allan GFinding: In 52 patients with type 2 diabetes, recombinant IGF-1 given with its binding protein cut insulin requirements by 54-82% and lowered fasting glucose by 32-37%. Side effects including edema, jaw pain and arthralgia occurred at a frequency of 4%.View study
1992[17]
Insulin-like growth factor-I (IGF-I) and especially IGF-I variants are anabolic in dexamethasone-treated ratsTomas FM, Knowles SE, Owens PC, Chandler CS, Francis GL, Read LCFinding: Compared LR3 IGF-I with native IGF-1 in rats: LR3 IGF-I binds IGF binding proteins far more weakly and binds the type 1 IGF receptor with roughly 3-fold lower affinity than native IGF-1, yet is more potent in vivo because less of it is sequestered by binding proteins.View study

Questions

Frequently asked

What's the difference between IGF-1 LR3 and regular IGF-1?

Regular IGF-1 gets grabbed by binding proteins within minutes and quickly becomes inactive. IGF-1 LR3 has been modified so those binding proteins can't hold onto it, leaving it free and biologically active rather than bound and inactivated within minutes. This means it actually reaches your muscles and stays active long enough to do its job [1][3].

Why do I need to eat when using IGF-1 LR3?

IGF-1 LR3 works similarly to insulin—it drives nutrients (including glucose) into your cells [7][8]. If you don't have enough glucose in your blood, you'll experience hypoglycemia: shakiness, dizziness, confusion, or worse. Always eat a meal with protein and carbs within 30 minutes of your injection.

Can I inject IGF-1 LR3 directly into specific muscles for localized growth?

Yes, many users inject intramuscularly into target muscles hoping for site-specific enhancement. However, IGF-1 LR3 circulates systemically regardless of injection site. Local injections may provide some preferential local effects, but the peptide will benefit your whole body, not just one muscle.

How long should I cycle IGF-1 LR3?

Most protocols run 4-6 weeks on, followed by at least 4 weeks off. This allows IGF-1 receptors to resensitize. Running too long without breaks can lead to receptor downregulation, diminishing returns, and increased side effect risk. Some users do 5 days on, 2 days off throughout their cycle.

Is IGF-1 LR3 the same as HGH?

No, they're different but related. Human Growth Hormone (HGH) stimulates your liver to produce IGF-1, which then causes many of HGH's effects [10]. IGF-1 LR3 bypasses this step—you're getting the active growth factor directly. Some users stack both for complementary effects, though this requires careful timing.

Will IGF-1 LR3 cause cancer?

IGF-1 is a growth factor that can stimulate cell division, which is concerning for anyone with existing cancer or pre-cancerous conditions [2][5]. However, there's no evidence that IGF-1 LR3 causes cancer in healthy individuals at typical doses. If you have any history of cancer or strong family history, discuss with an oncologist before using any growth-promoting compound.

Can I use IGF-1 LR3 for fat loss?

While IGF-1 LR3 can improve body composition by enhancing nutrient partitioning (more nutrients going to muscle versus fat), it's primarily an anabolic agent for muscle growth, not a fat burner [15]. For pure fat loss, compounds like HGH Fragment 176-191 or Tesamorelin might be more appropriate.

What happens if I experience hypoglycemia?

If you feel shaky, dizzy, sweaty, or confused, consume fast-acting sugar immediately—juice, glucose tablets, or regular soda work fast. Symptoms should improve within 10-15 minutes. If someone becomes unconscious, call emergency services immediately. Prevention is key: always eat with your injection.

Further reading

History & related research

History · since 1992

The Enhanced Growth Factor Revolution

A 25-Year Journey from Australian Innovation to Biotechnology Standard—How a Small Adelaide Team Engineered a Molecule That Powers Modern Medicine

Read the full history of IGF-1 LR3

Ready for the protocol?

Every dosing tier, administration route, timing note, and dose-adjustment rule for IGF-1 LR3, on one page.

Medical disclaimer

IGF-1 LR3 is an investigational research compound not approved by the FDA for human therapeutic use. This information is for educational purposes only and should not be construed as medical advice. Always consult with a qualified healthcare provider before starting any new supplement or treatment protocol.

Last updated: Feb 8, 2026